Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 292 institutions that hold shares in the stock, with a total of 177 Million shares, which have been reported (via 13F filing form) to have a value of $1.83 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
21,659,765
shares
|
$218 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.05%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
19,956,255
shares
|
$201 Million
0.0% of portfolio
|
Q2 2024
Added 8.22%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2025 Q1 2025 |
8,928,523
shares
|
$89.9 Million
5.64% of portfolio
|
Q1 2025
Reduced 1.73%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
8,700,000
shares
|
$87.6 Million
1.06% of portfolio
|
Q1 2025
Reduced 26.68%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
7,813,404
shares
|
$78.7 Million
0.0% of portfolio
|
Q1 2025
Added 4.19%
|
|
|
Alkeon Capital Management LLC
New York, NY |
May 14, 2025 Q1 2025 |
7,214,021
shares
|
$72.6 Million
0.11% of portfolio
|
Q1 2025
Added 1.69%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,286,536
shares
|
$53.2 Million
0.04% of portfolio
|
Q2 2023
Reduced 5.91%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
May 15, 2025 Q1 2025 |
5,189,665
shares
|
$52.3 Million
0.99% of portfolio
|
Q1 2025
Reduced 36.28%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
4,960,637
shares
|
$50 Million
0.0% of portfolio
|
Q1 2025
Added 2.84%
|
|
|
Rp Management, LLC
New York, NY |
May 02, 2025 Q1 2025 |
3,846,154
shares
|
$38.7 Million
42.27% of portfolio
|
Q4 2021
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
3,812,874
shares
|
$38.4 Million
0.02% of portfolio
|
Q1 2025
Added 382.58%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
3,419,046
shares
|
$34.4 Million
0.01% of portfolio
|
Q4 2024
Reduced 28.99%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
3,220,712
shares
|
$32.4 Million
0.06% of portfolio
|
Q1 2025
Added 28.84%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
May 14, 2025 Q1 2025 |
3,052,137
shares
|
$30.7 Million
0.01% of portfolio
|
Q1 2025
Reduced 4.1%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
May 05, 2025 Q1 2025 |
2,884,680
shares
|
$29 Million
0.2% of portfolio
|
Q1 2025
Reduced 1.93%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,403,186
shares
|
$24.2 Million
0.0% of portfolio
|
Q1 2025
Added 899.86%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,297,674
shares
|
$23.1 Million
0.0% of portfolio
|
Q1 2025
Added 37.94%
|
|
|
Eversept Partners, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,172,436
shares
|
$21.9 Million
1.8% of portfolio
|
Q1 2025
Added 9.7%
|
|
|
Jupiter Asset Management LTD
|
May 09, 2025 Q1 2025 |
2,148,969
shares
|
$21.6 Million
0.17% of portfolio
|
Q1 2025
Added 82.44%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,045,535
shares
|
$20.6 Million
0.04% of portfolio
|
Q1 2025
Added 15.29%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
May 15, 2025 Q1 2025 |
2,033,783
shares
|
$20.5 Million
0.06% of portfolio
|
Q1 2025
Added 28.72%
|
|
|
Rice Hall James & Associates, LLC
|
May 01, 2025 Q1 2025 |
2,027,568
shares
|
$20.4 Million
0.99% of portfolio
|
Q1 2025
Reduced 2.58%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,955,258
shares
|
$19.7 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.48%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
1,931,934
shares
|
$19.5 Million
0.0% of portfolio
|
Q1 2025
Added 49.62%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,922,038
shares
|
$19.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.93%
|